A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation.
Department of Pulmonology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch. Electronic address: s.a.j.m.vanriel@umcutrecht.nl.
S
S
van Riel
Department of Pathology, Vrije Universiteit VU Medical Center, Amsterdam, The Netherlands.
E
E
Thunnissen
Department of Pathology, Vrije Universiteit VU Medical Center, Amsterdam, The Netherlands.
D
D
Heideman
Pulmonology, Vrije Universiteit VU Medical Center, Amsterdam, The Netherlands.
E F
EF
Smit
Department of Pulmonology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch.
B
B
Biesma
D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077143:Docetaxel; D066246:ErbB Receptors / Q000235:genetics*; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D009154:Mutation; D009364:Neoplasm Recurrence, Local; D011799:Quinazolines / Q000627:therapeutic use; D055752:Small Cell Lung Carcinoma / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D043823:Taxoids / Q000627:therapeutic use; D000093542:Gemcitabine
D000970:Antineoplastic Agents; D011799:Quinazolines; D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors; D002945:Cisplatin; D000093542:Gemcitabine